Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Summit Trail Advisors LLC

Summit Trail Advisors LLC increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 5.4% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,820 shares of the company’s stock after purchasing an additional 1,065 shares during the quarter. Summit Trail Advisors LLC’s holdings in Oscar Health were worth $329,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of OSCR. Price T Rowe Associates Inc. MD raised its stake in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after acquiring an additional 2,409,160 shares during the period. Iron Triangle Partners LP acquired a new position in shares of Oscar Health during the fourth quarter worth about $18,781,000. First Light Asset Management LLC boosted its position in shares of Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after buying an additional 1,134,919 shares during the period. Renaissance Technologies LLC grew its stake in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after buying an additional 934,600 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Oscar Health by 161.4% in the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after buying an additional 860,226 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on OSCR. Robert W. Baird started coverage on Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price target for the company. Bank of America restated a “neutral” rating and issued a $21.00 target price (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.17.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Oscar Health news, EVP Ranmali Bopitiya sold 36,175 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $650,788.25. Following the transaction, the executive vice president now owns 251,885 shares of the company’s stock, valued at $4,531,411.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 in the last quarter. Insiders own 25.11% of the company’s stock.

Oscar Health Trading Down 2.6 %

NYSE OSCR opened at $22.33 on Tuesday. The company has a market capitalization of $5.40 billion, a price-to-earnings ratio of -56.15, a price-to-earnings-growth ratio of 43.42 and a beta of 1.61. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health, Inc. has a 12 month low of $4.72 and a 12 month high of $23.79. The company’s fifty day moving average price is $17.90 and its two-hundred day moving average price is $17.59.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same quarter last year, the company posted ($0.07) earnings per share. As a group, research analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.